The Peptide Report
Silicon Valley operators are quietly moving past melatonin in search of deeper, cleaner sleep. Here's why delta sleep-inducing peptide—delivered intranasally—has become the executive performance community's quiet favorite in 2026.
Silicon Valley's most performance-obsessed operators have quietly retired their prescription sleep aids. The science behind delta sleep inducing peptide—and why a doctor-formulated nasal spray is becoming the category leader's nightly ritual.
Inside the quiet sleep optimization shift happening among founders, VCs, and executive performers in 2026 — and why DSIP nasal spray has become the category-defining alternative to melatonin.
A quiet shift is happening in the upper ranks of Silicon Valley: high-performing executives are trading traditional sleep aids for doctor-formulated nasal sprays. Here's the science behind the trend.
Melatonin built the modern sleep aid market—and then the people who depend most on cognitive recovery quietly walked away from it. Here's what they're using instead, and why doctor-formulated sleep stacks have become the new standard in performance circles.
A quiet shift is underway in C-suites and founder circles: melatonin is out, multi-pathway sleep formulas are in. Here's what's driving the change — and the science behind the new generation of doctor-formulated sleep stacks.
